Alterity Therapeutics Limited earnings per share and revenue

ATHE earnings per share for the last semiannual are -0.44 USD whereas the estimation was -0.53 USD which accounts for 18.38% surprise. Company revenue for the same period amounts to 69.21 k USD despite the estimated figure of 2.30 M USD. Estimated earnings per share for the next semiannual are -0.26 USD, and revenue is expected to reach 2.76 M USD. Also watch annual changes over time to get a bigger picture of ATHE earnings per share and revenue dynamics.